Severe Cutaneous Adverse Reaction (SCAR) Clinical Research Consortium
Grant number: U54 AI205728-01
Principal Investigators
Lead Institution: Vanderbilt University Medical Center
Diseases Studied
- Stevens-Johnson syndrome and toxic epidermal necrolysis (SJS/TEN)
- Drug reaction with eosinophilia and systemic symptoms (DRESS)
- Acute generalized exanthematous pustulosis (AGEP)
- Generalized bullous fixed drug eruption (GBFDE)
- Severe cutaneous adverse reactions associated with immune checkpoint inhibitors (SCAR-iRAE)